While empirical research on AOD-9604 is in early stages, there have been almost no reported side effects, and the treatment has no downtime
A broad panel of antibodies was employed, including those for FOXO4, p53, phospho-p53, p21, p16, cleaved-Caspase3, BAX, BCL-2, testosterone synthesis enzymes (3-HSD, CYP11A1, CYP17A1), and various SASP factors (IL-1, IL-6, TNF-, TGF-)
As with all compounds discussed here, these are chemical research reagents intended strictly for laboratory and research purposes not for human consumption, diagnosis, treatment, or prevention of disease
Clinically, DSIP has shown promise in normalizing sleep patterns, managing narcolepsy, and even treating addiction withdrawal symptoms [1, 2, 3, 4, 5]
Long-term consistency matters more than one missed application